7Baggers
 Lantern Pharma (NASDAQ:LTRN) Will Have To Spend Its Cash Wisely  Yahoo Finance Sat, 15 Nov 2025 12:20:14 GMT
 lantern pharma inc. (nasdaq:ltrn) q3 2025 earnings call transcript  Insider Monkey Sat, 15 Nov 2025 07:02:49 GMT
 Lantern Pharma’s Earnings Call: Progress and Funding Needs  TipRanks Fri, 14 Nov 2025 06:02:21 GMT
 Lantern Pharma’s Q3 2025: Clinical and AI Progress  TipRanks Fri, 14 Nov 2025 05:19:59 GMT
 transcript : lantern pharma inc., q3 2025 earnings call, nov 13, 2025  MarketScreener Thu, 13 Nov 2025 18:05:16 GMT
 Lantern Pharma : Q3 2025 Earnings Call  MarketScreener Thu, 13 Nov 2025 15:29:08 GMT
 Lantern Pharma Achieves Key Milestones in Q3 2025  TipRanks Thu, 13 Nov 2025 14:07:33 GMT
 Lantern Pharma Earnings Preview  Benzinga Wed, 12 Nov 2025 17:02:57 GMT
 Lantern Pharma Q3 2025 Earnings Call Transcript  MarketBeat Wed, 12 Nov 2025 08:00:00 GMT
 Lantern Pharma (LTRN) Partners with New to The Street for Extens  GuruFocus Fri, 07 Nov 2025 15:03:29 GMT
 Lantern Pharma engages New to The Street for media program  TipRanks Fri, 07 Nov 2025 14:29:22 GMT
 Lantern Pharma : Corporate Overview  MarketScreener Mon, 03 Nov 2025 18:17:05 GMT
 lantern pharma presents clinical data from lp-284  TipRanks Tue, 28 Oct 2025 13:30:51 GMT
 Lantern Pharma (LTRN) Reports Promising Phase 1 Trial Results fo  GuruFocus Tue, 28 Oct 2025 07:00:00 GMT

Lantern Pharma Inc
(NASDAQ:LTRN) 

LTRN stock logo

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on the development of precision oncology therapies using artificial intelligence, genomics, and machine learning. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant...

Founded: 2013
Full Time Employees: 4
CEO: Panna L. Sharma  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends